IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Jul 2005 (Vol: 2005, Issue: 61)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
Don't Make Your Drug Deals Poison Pills Published: 1 Jul-2005
By: Fintan Walton
Abstract Fulltext:
Section: Deal Trackers
Dacogen (decitabine) Published: 5 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Section: Features
Serono Continues its Deal Making Spree through Collaborations with BioMarin and NovImmune Published: 1 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Anadys Lands Lucrative HCV Deal with Novartis Published: 1 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Royalty Rates Used in Pharmaceutical Agreements Published: 1 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Cystic Fibrosis Published: 1 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Section: General
Renovis and Pfizer Enter Substantial Agreement Published: 5 Jul-2005
By: Business Review Editor
Abstract
Vectura Group plc Published: 5 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
Merck Obtains License from BioXell to Develop TREM-1 Products Published: 5 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Cephalon Acquires Cancer Drug Trisenox® from Cell Therapeutics Published: 5 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Pfizer Broadens Anti-Infectives Business through Acquisition of Vicuron Published: 5 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Novartis and Hybridon to Develop Oligonucleotides for Asthma and Allergy Published: 5 Jul-2005
By: Business Review Editor
Abstract Fulltext:
Exelixis and Genentech Forge R&D Pact Published: 5 Jul-2005
By: Business Review Editor
Abstract Fulltext:

Login Problems

Please enter your username or email address and we will email you your login details.